Abstract
Although rutaecarpine, an alkaloid originally isolated from the unripe fruit of Evodia rutaecarpa, has been reported to reduce the systemic exposure of caffeine, the mechanism of this phenomenon is unclear. We investigated the microsomal enzyme activity using hepatic S-9 fraction and the plasma concentration-time profiles and urinary excretion of caffeine and its major metabolites after an oral administration of caffeine in the presence and absence of rutaecarpine in rats. Following oral administration of 80 mg/kg rutaecarpine for three consecutive days, caffeine (20 mg/kg) was given orally. Plasma and urine were collected serially for up to 24 h and the plasma and urine concentrations of caffeine and its metabolites were measured, and compared with those in control rats. The areas under the curve of both caffeine and its three major metabolites (paraxanthine, theophylline, and theobromine) were significantly reduced by rutaecarpine, indicating that caffeine was rapidly converted into the desmethylated metabolites, and that those were also quickly transformed into further metabolites via the hydroxyl metabolites due to the remarkable induction of CYP1A2 and 2E1. The significant induction of ethoxyresorufin O-deethylase, pentoxyresorufin O-depentylase, and p-nitrophenol hydroxylase strongly supported the decrease in caffeine and its major metabolites in plasma, as well as in urine. These results clearly suggest that rutaecarpine increases the metabolism of caffeine, theophylline, theobromine, and paraxanthine by inducing CYP1A2 and CYP2E1 in rats.
Similar content being viewed by others
References
Bechtel, Y. C., Bonaiti-Pellie, C., Poisson, N., Magnette, J., and Bechtel, P. R., A population and family study of Nacetyltransferase using caffeine urinary metabolites. Clin. Pharmacol. Ther., 54, 134–141 (1993).
Bista, S. R., Lee, S. K., Thapa, D., Kang, M. J., Seo, Y. M., Kim, J. H., Kim, D. H., Jahng, Y., Kim, J. A., and Jeong, T. C., Effects of oral rutaecarpine on the pharmacokinetics of intravenous chlorzoxazone in rats. Toxicol. Res., 24, 195–199 (2008).
Blank, J. A., Tucker, A. N., Sweatlock, J., Gasiewicz, T. A., and Luster, M. I., α-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin induced murine ethoxyresorufin O-deethylase activity and immunosuppression. Mol. Pharmacol., 32, 169–172 (1987).
Caubet, M. S., Comte, B., and Brazier, J. L., Determination of urinary 13C-caffeine metabolites by liquid chromatography-mass spectrometry: the use of metabolic ratios to assess CYP1A2 activity. J. Pharm. Biomed. Anal., 34, 379–389 (2004).
Chen, L., Bondoc, F. Y., Lee, M. J., Hussin, A. H., Thomas, P. E., and Yang, C. S., Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats. Drug Metab. Dispos., 24, 529–533 (1996).
Chiou, W. F., Liao, J. F., and Chen, C. F., Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J. Nat. Prod., 59, 374–378 (1996).
Chiou, W. L., Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level — time curve. J. Pharmacokinet. Biopharm., 6, 539–546 (1978).
Jan, W. C., Lin, L. C, Chen, C. F., and Tsai, T. H., Herb-drug interaction of Evodia rutaecarpa extract on the pharmacokinetics of theophylline in rats. J. Ethnopharmacol., 102, 440–445 (2005).
Koop, D. R., Hydroxylation or p-nitrophenol by rabbit ethanol inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol., 29, 399–404 (1986).
Lee, S. H., Kim, S. I., Park, J. G., Lee, E. S., and Jahng, Y., A simple synthesis of rutaecarpine. Heterocycles, 55, 1555–1559 (2001).
Lee, S. K., Kim, N. H., Lee, J., Kim, D. H., Lee, E. S., Choi, H. G., Chang, H. W., Jahng, Y., and Jeong, T. C., Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s. Planta Med., 70, 753–757 (2004a).
Lee, S. K., Lee, J., Lee, E. S., Jahng, Y., Kim, D. H., and Jeong, T. C., Characterization of in virto metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom., 18, 1073–1080 (2004b).
Lee, S. K., Lee, D. W., Jeon, T. W., Jin, C. H., Kim, G. H., Jun, I. H., Lee, D. J., Kim, S. I., Kim, D. H., Jahng, Y., and Jeong, T. C., Characterization of the phase 2 metabolites of rutaecarpine in rats by liquid chromatography-electrospray ionization-tandem mass spectrometry. Xenobiotica, 35, 1135–1145 (2005).
Lee, S. K., Bista, S. R., Jeong, H. M., Kim, D. H., Kang, M. J., Jahng, Y., and Jeong, T. C., The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats. Arch. Pharm. Res., 30, 1629–1634 (2007).
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265–275 (1951).
Lubet, R. A., Meyer, R. T., Cameron, J. W., Nims, R. W., Burke, M. D., Wolff, T., and Guengerich, F. P., Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys., 238, 43–48 (1985).
Moon, T. C., Murakami, M., Kudo, I., Son, K. H., Kim, H. P., Kang, S. S., and Chang, H. W., A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflamm. Res., 48, 621–625 (1999).
Nash, T., The colorimetrical estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J., 55, 416–421 (1953).
Tsai, T. H., Chang, C. H., and Lin, L. C., Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats. Planta Med., 71, 640–645 (2005).
Ueng, Y. F., Wang, J. J., Lin, L. C., Park, S. S., and Chen, C. F., Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa. Life Sci., 70, 207–217 (2001).
Ueng, Y. F., Don, M. J., Peng, H. C., Wang, S. Y., Wang, J. J., and Chen, C. F., Effects of Wu-chu-yu-tang and its compound herbs on drug-metabolizing enzymes. Jpn. J. Pharmacol., 89, 267–273 (2002).
Ueng, Y. F., Tsai, T. H., Don, M. J., Chen, R. M., and Chen, T. L., Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats. J. Pharm. Pharmacol., 57, 227–232 (2005).
Woo, H. G., Lee, C. H., Noh, M. S., Lee, J. J., Jung, Y. S., Baik, E. J., Moon, C. H., and Lee, S. H., Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in RAQ264.7 macrophages. Planta Med., 67, 505–509 (2001).
Yuan, R., Madani, S., Wei, X. X., Reynolds, K., and Huang, S. M., Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab. Dispos., 30, 1311–1319 (2002).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Noh, K., Seo, Y.M., Lee, S.K. et al. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats. Arch. Pharm. Res. 34, 119–125 (2011). https://doi.org/10.1007/s12272-011-0114-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0114-3